Evidence shows that prescription weight loss medications, such as GLP-1 receptor agonists, can effectively target brain signals that control hunger and fullness, aiding you in weight management when diet and exercise aren't enough
You need it
Moreover, eight categories of psychiatric AEs, namely, nervousness (ROR = 1.97, 95% CI = 1.852.11), stress (ROR = 1.28, 95% CI = 1.191.38), eating disorder (ROR = 1.57, 95% CI = 1.401.77), fear of injection (ROR = 1.96, 95% CI = 1.602.40), sleep disorder due to general medical conditioninsomnia type (ROR = 2.01, 95% CI = 1.602.52), binge eating (ROR = 2.70, 95% CI = 1.754.16), fear of eating (ROR 3.35, 95% CI = 1.656.78), and self-induced vomiting (ROR = 3.77, 95% CI = 1.778.03), were defined as GLP-1 RA-related psychiatric AEs through disproportionality analysis
244 , 359 LP362 (1989)
Choosing the right peptide therapy for you requires an understanding of the specific compounds and their evidence-backed applications